Search - tctmd.com

Displaying 821 - 840 of 3565

Sort: Relevancy | Date

Presentation TCT 2015

Valve Thrombosis After TAVR: Frequency, Clinical Recognition, and Management

Presenter: Isaac George, Augusto D. Pichard, Azeem Latib

October 15, 2015

Presentation TCT 2015

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

Presenter: Isaac George, Augusto D. Pichard

October 15, 2015

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Bleeding Events (Early and Late) After TAVR: Growing Importance and Often Misunderstood

Presenter: Isaac George, Augusto D. Pichard, Philippe Généreux

October 15, 2015

Presentation TCT 2015

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Isaac George, Augusto D. Pichard, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma

October 15, 2015

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: John D. Carroll, Ioanna Kosmidou, Danny Dvir

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Presenter: John D. Carroll, Ioanna Kosmidou, Howard C. Herrmann

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Case 3: Aortic Paravalvular Leak Closure Surgical Valve

Presenter: Chet Rihal, Robert Kumar

October 15, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

Presentation TCT 2015

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Presenter: Steven R. Bailey, Patrick W. Serruys, Federico De Marco

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Presenter: Howard C. Herrmann

October 15, 2015

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: Danny Dvir

October 15, 2015

Advertisement

Valve Thrombosis After TAVR: Frequency, Clinical Recognition, and Management

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Bleeding Events (Early and Late) After TAVR: Growing Importance and Often Misunderstood

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Case 3: Aortic Paravalvular Leak Closure Surgical Valve

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content